Adaptive Biotechnologies Corp
(ADPT)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 55,034 | 43,163 | 50,646 | 47,920 | 38,084 |
| Marketable Securities | 157,735 | 154,710 | 142,778 | 174,374 | 205,245 |
| Receivables | 44,821 | 44,285 | 43,583 | 41,731 | 40,814 |
| Inventories | 9,933 | 8,403 | 8,684 | 8,440 | 11,955 |
| TOTAL | $281,435 | $261,856 | $256,489 | $283,752 | $308,345 |
| Non-Current Assets | |||||
| PPE Net | 37,498 | 41,055 | 44,430 | 48,616 | 51,314 |
| Investments And Advances | 4,037 | 24,100 | 39,355 | 33,660 | 23,866 |
| Intangibles | 121,127 | 121,555 | 121,978 | 122,397 | 122,825 |
| Other Non-Current Assets | 46,513 | 48,071 | 48,600 | 50,951 | 52,156 |
| TOTAL | $209,175 | $234,781 | $254,363 | $255,624 | $250,161 |
| Total Assets | $490,610 | $496,637 | $510,852 | $539,376 | $558,506 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 10,267 | 6,908 | 6,362 | 7,265 | 7,351 |
| Accrued Expenses | 19,886 | 16,905 | 14,169 | 23,995 | 18,399 |
| Other current liabilities | 2,429 | 3,070 | 2,011 | 865 | N/A |
| TOTAL | $83,361 | $92,141 | $87,809 | $98,053 | $87,627 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 41,337 | 55,301 | 54,805 | 55,689 | 51,856 |
| Other Non-Current Liabilities | 201,791 | 204,907 | 207,986 | 211,607 | 214,550 |
| TOTAL | $202,996 | $224,960 | $232,822 | $238,838 | $247,305 |
| Total Liabilities | $286,357 | $317,101 | $320,631 | $336,891 | $334,932 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 152,665 | 152,274 | 151,917 | 148,582 | 147,580 |
| Common Shares | 15 | 15 | 15 | 14 | 14 |
| Retained earnings | -1,349,744 | -1,359,290 | -1,333,676 | -1,303,824 | -1,270,132 |
| Other shareholders' equity | 29 | -108 | -68 | -58 | 298 |
| TOTAL | $204,253 | $179,536 | $190,221 | $202,485 | $223,574 |
| Total Liabilities And Equity | $490,610 | $496,637 | $510,852 | $539,376 | $558,506 |